tiprankstipranks
Advertisement
Advertisement

LAB Stock Latest News

Is LAB a Buy, Before Earnings?
Pre-EarningsIs LAB a Buy, Before Earnings?
1d ago
LAB
Standard BioTools Receives Nasdaq Minimum Bid Price Deficiency Notice
PremiumCompany Announcements
Standard BioTools Receives Nasdaq Minimum Bid Price Deficiency Notice
10d ago
8K
LAB
Standard BioTools: Neutral Stance Amid Revenue Contraction Risk and M&A-Dependent Growth Outlook
PremiumRatings
Standard BioTools: Neutral Stance Amid Revenue Contraction Risk and M&A-Dependent Growth Outlook
2M ago
LAB
Standard BioTools Details SomaLogic Sale and Profitability Path
PremiumCompany Announcements
Standard BioTools Details SomaLogic Sale and Profitability Path
2M ago
8K
LAB
Standard BioTools reports Q4 EPS 5c vs (9c) last year
PremiumThe Fly
Standard BioTools reports Q4 EPS 5c vs (9c) last year
2M ago
LAB
Standard BioTools sees FY26 revenue $80M-$85M, consensus $79.73M
PremiumThe FlyStandard BioTools sees FY26 revenue $80M-$85M, consensus $79.73M
2M ago
LAB
Is LAB a Buy, Before Earnings?
Premium
Pre-Earnings
Is LAB a Buy, Before Earnings?
2M ago
LAB
Standard BioTools Completes Major Proteomics Business Divestiture
Premium
Company Announcements
Standard BioTools Completes Major Proteomics Business Divestiture
3M ago
8K
LAB
Standard BioTools completes sale of SomaLogic to Illumina
PremiumThe Fly
Standard BioTools completes sale of SomaLogic to Illumina
3M ago
LAB
ILMN
Standard BioTools sees Q4 revenue from cont. ops. $24M, consensus $18.5M
PremiumThe Fly
Standard BioTools sees Q4 revenue from cont. ops. $24M, consensus $18.5M
4M ago
LAB
Standard BioTools price target lowered to $1.35 from $1.55 at TD Cowen
PremiumThe Fly
Standard BioTools price target lowered to $1.35 from $1.55 at TD Cowen
6M ago
LAB
Standard BioTools Inc. Reports Q3 2025 Financial Results
PremiumCompany Announcements
Standard BioTools Inc. Reports Q3 2025 Financial Results
6M ago
LAB
Cautious Hold Rating for Standard BioTools Amid Economic Challenges and Uncertain Strategic Outlook
PremiumRatingsCautious Hold Rating for Standard BioTools Amid Economic Challenges and Uncertain Strategic Outlook
6M ago
LAB
Standard BioTools Implements Restructuring for Future Growth
Premium
Company Announcements
Standard BioTools Implements Restructuring for Future Growth
6M ago
8K
LAB
LAB Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
LAB Upcoming Earnings Report: What to Expect?
6M ago
LAB
Standard BioTools Announces Workforce Reduction Plan
PremiumCompany Announcements
Standard BioTools Announces Workforce Reduction Plan
8M ago
8K
LAB
Standard BioTools Announces Strategic Restructuring Plan
PremiumCompany Announcements
Standard BioTools Announces Strategic Restructuring Plan
8M ago
8K
LAB
Standard Biotools Inc. Faces Challenges in SomaScan Divestiture: Potential Risks and Strategic Imperatives
PremiumCompany Announcements
Standard Biotools Inc. Faces Challenges in SomaScan Divestiture: Potential Risks and Strategic Imperatives
9M ago
LAB
Standard BioTools downgraded to Hold from Buy at TD Cowen
PremiumThe Fly
Standard BioTools downgraded to Hold from Buy at TD Cowen
9M ago
LAB
Hold Rating for Standard BioTools Amid Uncertainty Following SomaLogic Sale and Market Challenges
PremiumRatingsHold Rating for Standard BioTools Amid Uncertainty Following SomaLogic Sale and Market Challenges
9M ago
LAB
Standard BioTools Delays Quarterly Report Filing
Premium
Company Announcements
Standard BioTools Delays Quarterly Report Filing
9M ago
LAB
Standard BioTools Reports Q2 2025 Financial Results
Premium
Company Announcements
Standard BioTools Reports Q2 2025 Financial Results
9M ago
LAB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >